![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » HeartWare Steps Away From Proposed Acquisition of Valtech Cardio
HeartWare Steps Away From Proposed Acquisition of Valtech Cardio
![](https://www.fdanews.com/ext/resources/test/Device_Images4/HeartWare-pic-2.png?t=1434573744&width=430)
HeartWare International has terminated its proposed acquisition of Valtech Cardio.
“While we continue to believe Valtech's portfolio of mitral and tricuspid interventional tools holds tremendous promise, HeartWare finds itself in a different set of circumstances than when we first entered into the agreement,” says Doug Godshall, president and chief executive officer of HeartWare.
Under the agreement, HeartWare will make a $30 million loan to Valtech in the form of a convertible promissory note. — Jonathon Shacat
Upcoming Events
-
21Oct